Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Omega-3 fat tied to less cancer-related fatigue

NEW YORK (Reuters Health) - Breast cancer survivors who eat a healthy dose of omega-3 fats may have some extra energy throughout their day, a new study suggests.

Herceptin or Herceptin Combination May Be Most Effective Before Surgery

Learn about results from two studies that showing the effectiveness of trastuzumab (Herceptin) or trastuzumab plus lapatinib (Tykerb) given with chemotherapy before surgery in early-stage and locally advanced HER2 positive breast cancer.

Bevacizumab Studies Show Benefit in Early Breast Cancer

Learn about results from two studies that show adding bevacizumab (Avastin) to chemotherapy before surgery improves the rate of pathologic complete response in HER2 negative breast cancer that has not traveled to other parts of the body.

Do too many older women get radiation for cancer?

NEW YORK (Reuters Health) - Some elderly women with early-stage breast cancer may be getting extra treatment that does them little good but comes with costs and possible side effects, according to a new study.

ASCO Recommends Palliative Care with Standard Cancer Treatment

Learn how new research has prompted the American Society of Clinical Onclolgy (ASCO) to recommend that doctors offer palliative care alongside standard medical treatment for people diagnosed with metastatic cancers.

"Chemo brain" may persist years after treatment

NEW YORK (Reuters Health) - Women on chemotherapy for breast cancer may have tiny memory and thinking impairments compared with cancer-free women more than 20 years after their treatment, Dutch researchers have found.

Astra takes brand cancer drug straight to patients

(Reuters) - AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.

Older Women Benefit Less from Treatment Breakthroughs

Women 65 and older are less likely to survive breast cancer than their younger counterparts, two recent studies suggest.

Rare mutations tied to breast, pancreatic cancers

NEW YORK (Reuters Health) - Mutations in genes that fix mismatched DNA may put people at extra risk for breast cancer and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report suggests.

Most women with cancer want a role in decisions

NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.